Investopedia explains 'Confidential Treatment Order - CTO'
Companies would typically seek a CTO in order to keep information that would otherwise put it at a disadvantage, a secret. For example, a company may apply for such an order to keep information regarding a pricing arrangement made with a partner, secret, since competitors finding out this information may go after the partner with a more competitive price.
Or starting new developments in other cancer indications. They obviously have the resources to do plenty of that. They have a track record of being fiscally responsible, and now they have an incredible resource in Merk. This is NOT a trading stock. THLD is an investment ! Better buy and hold before you miss the boat. Getting in at any single digit is still a bargain !!
Hey Just, sorry thought you were Alan. Good morning to you. Even with the stock action today, the board seems to be bored. I know most of us have beat the topic to a pulp, but since you opened the door again, why not. It's always fun to speculate, and THLD does have very good prospects for a US partnership or a full on takeover by Merk KGaA, OR mega buyout by another Large Pharma that makes Merk look like a lemonaid stand. The latest filing ?? Routine precaution by THLD to protect it's intellectual property, or something much bigger on the horizon ? Judging by the stock movement yesterday and today, maybe others are wondering the same ?
The CTO is in regards to the License and Co-Development Agreement between the Company and Merck KGaA, dated February 2, 2012. The CTO specifically references Exhibit 10.1 in the 10-Q report for June 30, 2012. and filed 8/6/12.
Among some of the items being kept confidential are milestone events and payments, and net sales levels relative to royalty terms.
Stay Long and Prosper